NIDEK, a global leader in laser and diagnostic instrumentation for the eye care industry, announced today that the United States Food & Drug Administration (FDA) has approved the use of the OPD-Scan III aberrometer and update the Final Fit software to facilitate compatibility with a new aberrometer to perform topography-assisted laser in-situ keratomileusis (LASIK).
Mr. Motoki Ozawa, President of NIDEK stated, â€œWe are pleased to have this approval, and confident the results reflect the quality of our products.â€
This demonstrates NIDEKâ€™s commitment to providing an innovative, technologically superior excimer platform for laser vision correction surgery. Furthermore, NIDEKâ€™s NAVEX Quest; EC-5000 Excimer Laser System is a perfect pairing to our strong, world-class product portfolio in unsurpassed diagnostic, surgical instrumentation, optical finishing and dispensing products for vision care.
Founded in Gamagori, Japan in 1971, NIDEK continues to be a global leader in research and development, design, manufacture and distribution of ophthalmic equipment. The United States subsidiary based in Silicon Valley, California, provides sales
and service for ophthalmic lasers, refractive lasers, and many advanced diagnostic devices.
For further information contact:
Director of Sales & Marketing
Phone: 800-223-9044â€“ ext. 713